Merit Medical Systems, Inc recalls Merit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution…
The stated reason: Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with endotoxins.
Merit Medical Systems, Inc began a drug recall on February 24, 2006 whose reported distribution included Ohio. FDA
What the record shows
beginning February 24, 2006, in a drug recall whose distribution included Ohio. FDA graded it Class I — a reasonable probability that use will cause serious health consequences or death. Quantity affected: 2470 kits. The recall is listed as terminated. FDA
Context
By the numbers
- Date of record: February 24, 2006 FDA
- Recall number: D-040-2013 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Merit Medical Systems, Inc FDA
- Product: Merit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution, 18 mL Single Dose Bottle, NDC… FDA
- Reason for recall: Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-040-2013 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Merit Medical Systems, Inc |
| Product | Merit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution, 18 mL Single Dose Bottle, NDC 23731-8100-8, Sterile. |
| Reason for recall | Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with endotoxins. |
| Classification | Class I — a reasonable probability that use will cause serious health consequences or death |
| Recall type | drug |
| Quantity | 2470 kits |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20060224 |
| Reported | 20121114 |
| Distribution | Connecticut, Maryland, Ohio, and South Carolina. |
| Firm location | South Jordan, UT, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.